- Filed
- May 6, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 165M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 156.63M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $106M |
| Capex | Q1 2026 · Mar 31, 2025 | $78M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$980M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$1.13B |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $12.75B |
| Long Term Debt | Q1 2026 · Dec 31, 2025 | $12.77B |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $9.84B |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $11.47B |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $56.69B |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $55.89B |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $106.92B |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $108.46B |
| Total Assets | Q1 2026 · Mar 31, 2026 | $170.24B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $170B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $14.06 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $9.64 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $14.24 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $9.74 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $674M |
| Sga Expense restated | Q1 2026 · Mar 31, 2025 | $615M |
| Net Income | Q1 2026 · Mar 31, 2026 | $2.21B |
| Net Income | Q1 2026 · Mar 31, 2025 | $1.51B |
| Operating Income | Q1 2026 · Mar 31, 2026 | $2.81B |
| Operating Income | Q1 2026 · Mar 31, 2025 | $1.7B |
| Revenue | Q1 2026 · Mar 31, 2026 | $6.7B |
| Revenue | Q1 2026 · Mar 31, 2025 | $5.28B |